Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Clozapine alone versus clozapine and risperidone for refractory schizophrenia.

Gerson SL.

N Engl J Med. 2006 Apr 27;354(17):1846-8; author reply 1846-8. No abstract available.

PMID:
16642587
2.

Clozapine: the commitment to patient safety.

Alphs LD, Anand R.

J Clin Psychiatry. 1999;60 Suppl 12:39-42. Review.

3.

Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine.

Meltzer HY.

J Clin Psychiatry. 2005 Apr;66(4):530-3. Review. No abstract available.

PMID:
15816797
4.

[Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].

Güzelcan Y, Scholte WF.

Tijdschr Psychiatr. 2006;48(4):295-302. Review. Dutch.

5.

[Clozapine].

Inada K, Ishigooka J.

Nihon Rinsho. 2013 Apr;71(4):678-83. Review. Japanese.

PMID:
23678599
6.

Use of cytokines in clozapine-induced agranulocytosis.

Chin-Yee I, Bezchlibnyk-Butler K, Wong L.

Can J Psychiatry. 1996 Jun;41(5):280-4. Review.

PMID:
8793147
7.

[Clozapine in the treatment of under-age schizophrenia].

Haapasalo-Pesu KM.

Duodecim. 2009;125(15):1635-8. Review. Finnish.

PMID:
19769179
8.

Who should receive clozapine?

Marder SR, Van Putten T.

Arch Gen Psychiatry. 1988 Sep;45(9):865-7. Review. No abstract available.

PMID:
2901253
9.

Focus on clozapine.

Naheed M, Green B.

Curr Med Res Opin. 2001;17(3):223-9. Review.

PMID:
11900316
10.

Clozapine-associated agranulocytosis: risk and aetiology.

Krupp P, Barnes P.

Br J Psychiatry Suppl. 1992 May;(17):38-40. Review.

PMID:
1418887
11.

The expanding indications for clozapine.

Young CR, Longhurst JG, Bowers MB Jr, Mazure CM.

Exp Clin Psychopharmacol. 1997 Aug;5(3):216-34. Review.

PMID:
9260069
12.

[Clozapine in the treatment of schizophrenia].

Raitasuo V.

Duodecim. 2000;116(11):1199-204; quiz 1205. Review. Finnish. No abstract available.

PMID:
11989005
13.

Management of the adverse effects of clozapine.

Young CR, Bowers MB Jr, Mazure CM.

Schizophr Bull. 1998;24(3):381-90. Review.

PMID:
9718630
14.
15.

Clozapine use in children and adolescents.

Gogtay N, Rapoport J.

Expert Opin Pharmacother. 2008 Feb;9(3):459-65. doi: 10.1517/14656566.9.3.459 . Review.

PMID:
18220495
16.

Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.

Honigfeld G, Arellano F, Sethi J, Bianchini A, Schein J.

J Clin Psychiatry. 1998;59 Suppl 3:3-7. Review.

17.

Clozapine. A novel antipsychotic agent.

Baldessarini RJ, Frankenburg FR.

N Engl J Med. 1991 Mar 14;324(11):746-54. Review. No abstract available.

PMID:
1671793
18.

Clozapine: balancing safety with superior antipsychotic efficacy.

Meltzer HY.

Clin Schizophr Relat Psychoses. 2012 Oct;6(3):134-44. Review.

PMID:
23006238
19.

Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.

Remington G, Lee J, Agid O, Takeuchi H, Foussias G, Hahn M, Fervaha G, Burton L, Powell V.

Expert Opin Drug Saf. 2016 Sep;15(9):1193-203. doi: 10.1080/14740338.2016.1191468. Epub 2016 Jun 1. Review.

PMID:
27207070
20.

Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.

Lerma-Carrillo I, Molina JD, Cuevas-Durán T, González-Parra S, Blasco-Fontecilla H, Andrade-Rosa C, López-Muñoz F, Alamo C.

Clin Neuropharmacol. 2007 Mar-Apr;30(2):114-21. Review.

PMID:
17414944

Supplemental Content

Support Center